Mazdutide

Mazdutide is a synthetic peptide under investigation as a dual agonist of GLP-1 and glucagon receptors, similar in concept to other dual-agonist metabolic compounds. Its design aims to integrate incretin-like effects with glucagon receptor engagement to broaden metabolic pathway modulation. Mechanistic research typically focuses on appetite and satiety signalling, glycaemic control pathways, and energy expenditure markers. Studies evaluate receptor-specific signalling outputs, endocrine biomarker profiles, and metabolic readouts (such as glucose and lipid markers) to understand how combined GLP-  1/glucagon agonism shapes systemic metabolism.

‍

‍

‍

‍

‍

‍

‍

‍

‍